Abstract
We report a case of giant pituitary adenoma in a child. Computerized tomography (CT) scan revealed a suprasellar extension tumor mass with hydrocephalus. There was no clinical evidence of acromegaly, gigantism, and other hormonal symptoms. Endocrinologic studies showed within normal value of serum growth hormone (GH: 4.2 ng/mL) and slightly increased levels of prolactin (PRL: 78 ng/mL) and other pituitary hormone values were within normal range. On suppression test by bromocryptin, both GH and PRL levels were reduced. Histopathological findings revealed that the tumor consisted of predominantly chromophobic and partly eosinophilic adenoma cells. Immunohistochemical staining detected GH and PRL in a small number of distinctly different adenoma cells, respectively. Nonradioactivein situ hybridization (ISH) also showed GH and PRL mRNA expression in identical immunopositive cells. Electron microscopy (EM) demonstrated adenoma cells with moderate or small numbers of two types of dense granules and without fibrous body which are characteristic of sparsely granulated GH-cell adenomas. The adenoma does not fit into any classification but may be an atypical acidophil cell line tumor showing focal differentiation toward both GH and PRL cells.
Similar content being viewed by others
References
Klibanski A, Zervas NT, Kovacs K, Chester Ridgway E. Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 66: 806–811, 1987.
Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS. Silent somatotroph adenomas of the human pituitary. Am J Pathol 134: 345–353, 1989.
Yamada S, Sano T, Stefaneanu L, Kovacs K, Aiba T, Sawano S, Shishiba Y. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. J Clin Endocr Metab 76: 352–356, 1993.
Furuhata S, Kameya T, Otani M, Shimamoto Y, Asada H, Toya S. Silent mixed growth hormone cell-prolactin cell pituitary adenoma. Endocr Pathol 2: 230–234, 1991.
Kameya T, Tsumuraya M, Adachi I, Abe K, Ichikizaki K, Toya S, Demura R. Ultrastructure, immunohistochemistry and hormone release of pituitary adenomas in relation to prolactin production. Virchows Arch [Pathol Anat] 387: 31–46, 1981.
Furuhata S, Nemoto N, Miyazawa S, Otani M, Toya S, Kameya T. Pitfalls in the double labelling immunoelectron microscopy using one face of the grid. J Electron Microsc 41: 120–122, 1992.
Larsson LI, Hougaard DM. Optimization of non-radioactive in situ hybridization: image analysis of varying pretreatment, hybridization and probe labelling conditions. Histochemistry 93: 347–354, 1990.
Lloyd RV, Cano M, Chandler WF, Barkan AL, Horvath E, Kovacs K. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization. Am J Pathol 134: 605–613, 1989.
Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization. Am J Pathol 137: 479–488, 1990.
Saeger W, Uhlig H, Baz E. In situ hybridization for different mRNA in GH-secreting and in inactive pituitary adenomas. Path Res Pract 187: 559–563, 1991.
Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, Nakane T, Sugita K, Matsui N. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease. J Neurosurg 72: 262–267, 1990.
Sakurai T, Seo H, Yamamoto N, Nagaya T, Nakane T, Kuwayama A, Kageyama N, Matsui N. Detection of mRNA of prolactin and ACTH in clinically nonfunctioning pituitary adenomas. J Neurosurg 69: 653–659, 1988.
Dutilh B, Bebear C, Taylor-Robinson D, Grimont PAD. Detection of Chlamydia trachomatis by in situ hybridization with sulfonated total DNA. Ann Inst Pasteur/Microbiol 139: 115–128, 1988.
Morimoto H, Monden T, Shimano T, Higashiyama M, Tomita N, Murotani M, Matsuura N, Nakamori S, Furukawa J, Okuda H, Mori T. Use of sulfonated probes for in situ detection of amylase mRNA in formalinfixed paraffin sections of human pancreas and submaxillary gland. Lab Invest 57: 737–741, 1987.
Nur I, Reinhartz A, Hyman HC, Razin S, Herzberg M. Chemiprobe, a non-radioactive system for labelling nucleic acid—principles and application. Ann Biol Clin 47: 601–606, 1989.
Kovacs K, Horvath E. Tumors of the pituitary gland. Atlas of tumor pathology. 2nd ser. Washington, DC: Fascicle 21, Armed Forces Institute of Pathology, 1986.
Horvath E, Kovacs K. Pathology of the pituitary gland. In: Ezrin C, Horvath E, Kaufman B, Kovacs K, Weiss MH, eds. Pituitary diseases. Boca Raton, FL: CRC, 1980; 1–83.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Naritaka, H., Kameya, T., Sato, Y. et al. An atypical acidophil cell line tumor showing focal differentiation toward both growth hormone and prolactin cells. Endocr Pathol 6, 239–246 (1995). https://doi.org/10.1007/BF02739888
Issue Date:
DOI: https://doi.org/10.1007/BF02739888